These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 2020360)

  • 1. Erythrocyte sedimentation rate and related factors in end-stage renal failure.
    Warner DM; George CR
    Nephron; 1991; 57(2):248. PubMed ID: 2020360
    [No Abstract]   [Full Text] [Related]  

  • 2. The erythrocyte sedimentation rate in end-stage renal failure.
    Bathon J; Graves J; Jens P; Hamrick R; Mayes M
    Am J Kidney Dis; 1987 Jul; 10(1):34-40. PubMed ID: 3605082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors influencing erythrocyte sedimentation in patients with chronic renal failure.
    Shusterman N; Kimmel PL; Kiechle FL; Williams S; Morrison G; Singer I
    Arch Intern Med; 1985 Oct; 145(10):1796-9. PubMed ID: 4037939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum immunoreactive erythropoietin in patients with end stage renal disease.
    Gimenez LF; Watson AJ; Spivak JL
    Prog Clin Biol Res; 1990; 352():493-504. PubMed ID: 2402519
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparison of haemoglobin levels and blood-transfusion requirements in patients on haemodialysis and on chronic ambulatory peritoneal dialysis.
    Naiker IP; Seedat YK
    S Afr Med J; 1985 Nov; 68(11):785-6. PubMed ID: 4071323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The erythrocyte sedimentation rate, C-reactive protein, plasma fibrinogen and viscosity in chronic renal disease patients with infection.
    Ishak R; Hassan K
    Malays J Pathol; 1989 Aug; 11():29-31. PubMed ID: 2632997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Dosage of erythropoietin in children treated with hemodialysis and continuous ambulatory peritoneal dialysis].
    Sieniawska M; Roszkowska-Blaim M
    Pediatr Pol; 1995 Dec; 70(12):1023-8. PubMed ID: 8649941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inflammatory markers as mortality predictors in continuous ambulatory peritoneal dialysis patients.
    Jovanovic DB; Stosović MD; Gojakovic BM; Jovanovic NZ; Stanojevic-Stosovic MLj; Simic-Ogrizovic SP; Naumovic RT
    Ren Fail; 2015 Mar; 37(2):230-6. PubMed ID: 25394528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum oxalate in chronic renal failure.
    Borland WW; Payton CD; Simpson K; Macdougall AI
    Nephron; 1987; 45(2):119-21. PubMed ID: 3561621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The effect of hemodialysis and continuous ambulatory peritoneal dialysis on renal anemia].
    Stojimirović B; Grujić-Adanja G
    Srp Arh Celok Lek; 1997; 125(5-6):163-7. PubMed ID: 9265238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of serum amyloid-A as mortality predictor in continuous ambulatory peritoneal dialysis patients.
    Agilli M; Aydin FN
    Ren Fail; 2015 Jun; 37(5):914. PubMed ID: 25761787
    [No Abstract]   [Full Text] [Related]  

  • 12. Do erythrocyte sedimentation rate and C-reactive protein levels have diagnostic usefulness in patients with renal failure?
    Arik N; Bedir A; Günaydin M; Adam B; Halefi I
    Nephron; 2000 Oct; 86(2):224. PubMed ID: 11015011
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparison of clinical and laboratory parameters in patients with end-stage renal failure in the outcome of chronic glomerulonephritis and patients with end-stage renal failure in the outcome of other diseases.
    Popova JA; Yadrihinskaya VN; Krylova MI; Sleptsovа SS; Borisovа NV
    Wiad Lek; 2016; 69(6):739-741. PubMed ID: 28214807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of depression with markers of nutrition and inflammation in chronic kidney disease and end-stage renal disease.
    Kalender B; Ozdemir AC; Koroglu G
    Nephron Clin Pract; 2006; 102(3-4):c115-21. PubMed ID: 16282695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Fibronectin in patients with chronic renal failure undergoing dialysis].
    Hou FF; Zhang X
    Zhonghua Nei Ke Za Zhi; 1988 Jun; 27(6):348-51, 389. PubMed ID: 3197506
    [No Abstract]   [Full Text] [Related]  

  • 16. Subcutaneous erythropoietin in the treatment of renal anaemia.
    Drinovec J; Varl J
    Przegl Lek; 1992; 49(1-2):38-40. PubMed ID: 1455004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ischemia-modified albumin, a predictive marker of major adverse cardiovascular events in continuous ambulatory peritoneal dialysis patients.
    Su X; Zhang K; Guo F; Yuan B; Wang C; Xiao L; Wang J; Huang H
    Clin Biochem; 2013 Oct; 46(15):1410-3. PubMed ID: 23796881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical analysis of 228 patients treated with penctoneal dialysis].
    Li J; Yang B; Cai Y
    Hunan Yi Ke Da Xue Xue Bao; 2002 Feb; 27(1):74-6. PubMed ID: 12575245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The clinical effects of recombinant human erythropoietin for the treatment of anemia in end stage renal disease patients on dialysis.
    Uthayanaka Y; Jirajan B; Krairithichai U; Jantavanich N
    Southeast Asian J Trop Med Public Health; 1993 Sep; 24(3):577-82. PubMed ID: 8160072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced nocturnal blood pressure fall is similar in continuous ambulatory peritoneal dialysis to that in hemodialysis and undialysed end-stage renal disease.
    Jones MA; Sharpstone P; Dallyn PE; Kingswood JC
    Clin Nephrol; 1994 Oct; 42(4):273-5. PubMed ID: 7834923
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.